Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic cancer. Poly-chemotherapy with cytotoxic and genotoxic drugs causes substantial toxicity and more specific therapies targeting the underlying molecular lesions are highly desired. Perturbed Ras signaling is prevalent in T-ALL a...
Main Authors: | Olga Ksionda, Marsilius Mues, Anica M Wandler, Lisa Donker, Milou Tenhagen, Jesse Jun, Gregory S Ducker, Ksenia Matlawska-Wasowska, Kevin Shannon, Kevan M Shokat, Jeroen P Roose |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5969748?pdf=render |
Similar Items
-
High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions
by: Marsilius Mues, et al.
Published: (2019-04-01) -
PI 3-kinase and disease
by: Cantley Lewis C
Published: (2012-06-01) -
Revisiting PI3-kinase signalling in angiogenesis
by: Piotr Kobialka, et al.
Published: (2019-12-01) -
PI 3-kinase signalling in Dictyostelium chemotaxis
by: Hoeller, Oliver
Published: (2007) -
Dissecting signalling downstream of PI 3-Kinase and PTEN
by: Kriplani, Nisha
Published: (2016)